MSM stock news
This page provides real-time market news, earnings updates, and company announcements related to MSC Industrial Direct Company, Inc. (MSM).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-16 17:08 EST
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
Finviz2026-03-05 13:33:09
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
Finviz2026-03-06 12:33:58
Capital Clean Energy Carriers Corp. Announces Changes to Our Board of Directors
Finviz2026-03-09 13:27:14
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-09 20:06:47
Longeveron Announces Private Placement of up to $30 Million
Finviz2026-03-10 13:07:02
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
Finviz2026-03-11 10:34:12
Longeveron Announces Closing of Private Placement of up to $30 Million
Finviz2026-03-11 20:09:57
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
Finviz2026-03-11 23:24:50
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026
Finviz2026-03-12 13:10:00
MSC Industrial Supply Co. to Webcast Review of Fiscal 2026 Second Quarter Results
Finviz2026-03-12 20:36:43
Studio City International Holdings Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2025
Finviz2026-03-13 11:54:44
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Finviz2026-03-17 20:09:45
Main Street Prices Public Offering of $200,000,000 Million of 6.95% Notes due 2029
Finviz2026-03-27 21:13:09
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
Finviz2026-03-30 12:24:09
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
Finviz2026-03-30 12:48:48
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Finviz2026-04-01 10:48:48
Main Street Announces Follow-On Investment
Finviz2026-04-01 11:03:12
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Finviz2026-04-08 13:18:12
MSC Income Fund Announces First Quarter 2026 Private Loan Portfolio Activity
Finviz2026-04-09 11:03:42
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
Finviz2026-04-13 13:03:12
Longeveron Announces Private Placement of up to $30 Million
Finviz2026-03-10 13:07:02
Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
Finviz2026-03-11 10:34:12
Longeveron Announces Closing of Private Placement of up to $30 Million
Finviz2026-03-11 20:09:57
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
Finviz2026-03-11 23:24:50
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026
Finviz2026-03-12 13:10:00
MSC Industrial Supply Co. to Webcast Review of Fiscal 2026 Second Quarter Results
Finviz2026-03-12 20:36:43
Studio City International Holdings Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2025
Finviz2026-03-13 11:54:44
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Finviz2026-03-17 20:09:45
Main Street Prices Public Offering of $200,000,000 Million of 6.95% Notes due 2029
Finviz2026-03-27 21:13:09
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
Finviz2026-03-30 12:24:09
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
Finviz2026-03-30 12:48:48
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Finviz2026-04-01 10:48:48
Main Street Announces Follow-On Investment
Finviz2026-04-01 11:03:12
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Finviz2026-04-08 13:18:12
MSC Income Fund Announces First Quarter 2026 Private Loan Portfolio Activity
Finviz2026-04-09 11:03:42
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
Finviz2026-04-13 13:03:12
MSM stock chart
MSM stock detailsMSM stock price change
On the last trading day, MSM stock closed at 95.78 USD, with a price change of 0.43% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more